权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Prevent TB: Application of choice architecture to implement TB preventive therapy in South Africa

预防结核病：应用选择架构在南非实施结核病预防治疗

基本信息

批准号：
10597158
负责人：
CHRISTOPHER J HOFFMANN
金额：
$ 56.81万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-02-28 至 2026-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10597158
关键词：
Acquired Immunodeficiency Syndrome Address Adherence Adoption Adult Advocacy Africa Africa South of the Sahara Anemia Architecture Area Automobile Driving Caring Cause of Death Cessation of life Characteristics Clinic Clinical Cluster randomized trial Cognitive Complex Country Cryptococcus Decision Making Disease Drug resistance Effectiveness Eligibility Determination Emergency Situation Environment Exposure to Goals Guidelines HIV Health Health Personnel Hepatotoxicity Immunization Incidence Individual International Intervention Interview Knowledge Leadership Liver Maintenance Measurement Morbidity - disease rate Outcome Paper Patient Self-Report Patients Persons Pharmaceutical Preparations Prevention Preventive therapy Printing Procedures Process Provider Questionnaires Random Allocation Randomized Reach, Effectiveness, Adoption, Implementation, and Maintenance Recommendation Reporting Research Research Priority Risk Self Assessment Services Shapes South Africa South African Structure System Testing Theory of Change Time Tuberculosis Tuberculosis diagnosis Uncertainty United States National Institutes of Health Work antigen test antiretroviral therapy arm behavioral economics co-infection cognitive load compliance behavior experience forgetting implementation fidelity implementation intervention implementation measures implementation process implementation strategy improved low and middle-income countries mortality patient oriented prescription opioid pressure prevent primary outcome programs provider-level barriers randomized trial recruit statistics theories trial comparing

项目摘要

PROJECT SUMMARY The availability of antiretroviral therapy (ART) has markedly reduced leading causes of HIV-related mortality and morbidity in Africa, including tuberculosis (TB). Yet TB remains the leading cause of death among people with HIV. Use of TB preventive therapy (TPT) reduces TB incidence and death, even among people receiving ART. Although the benefits of TPT among people with HIV have been known for 30 years and international and national guidelines provide clear prescribing recommendations, TPT is poorly prescribed. Overall in low and middle income countries 10-30% of people with HIV eligible for TPT receive it. For those who do receive TPT along with ART, adherence is generally good. Multiple system and provider level barriers appear to be driving anemic TPT prescribing. Several of these barriers have caused TPT prescribing to be the exception rather that the routine – barriers based on complex procedures implemented for inaccurate concerns. Primary among are efforts to completely “rule-out” active TB and concerns for potential liver problems with TPT. Notably, a study focused on more complex (and more sensitive) TB diagnosis resulted in increased mortality in the arm with greater TB diagnosis. That arm also had delayed and lower TPT prescribing. This study seeks to use choice architecture to make TPT prescribing the usual or “default” with not-prescribing occurring only when the clinician has a real concern (e.g. high concern for TB disease). The effectiveness of the choice architecture-based implementation strategy will be compared to the usual implementation in a cluster- randomized trial. Clinics will be the unit of randomization with all patients receiving services at a study clinic receiving uniform TPT implementation. The primary outcome will be the proportion of patients initiating ART who also receive TPT. The underlying concept of choice architecture is that optimizing decision making can lead to reduced cognitive load. Thus we propose to compare cognitive load regarding TPT prescribing between study arms. We will also assess congruence of the prescribing approach with clinic work flow, acceptability to providers, implementation measures, and patient-level implementation (e.g. receipt of TPT, adherence, patient reported problems). This study has the potential to lead the way in reshaping the delivery of TPT and other routine services in clinics in South Africa and similar settings. Should this implementation strategy prove effective it will contribute to national and global goals to reduce HIV-associated mortality and TB incidence.

项目总结